Research on Medical- Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016


Albany, NY -- (SBWIRE) -- 01/22/2016 -- Recently Syndicates Research Report And Present Overview On "Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology And Pipeline Analysis, 2016"

To View Complete Report @

"Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016" emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.

Report Highlights:

CAR-T cell Therapy Pipeline scenario
Collaborations & partnering deals
Current Prominent Research Areas and Key Players
Pipeline product profiles CAR-T Technologies and Targeted Antigens
Licensing opportunities
Market Drivers and Barriers

Download The sample Copy Of This Report:


Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information

Coverage of global CAR-T cell therapies under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Highlights of licensing & collaboration opportunities and funding details

Highlights of latest CAR-T technologies and innovative companies

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

Explore All Therapeutic Area Market Research Reports @

Reason to buy

Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities

Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas

Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies

Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development

Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years

Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising pipeline